About MS Research

brain image

Canada’s leadership in Multiple Sclerosis research

Canada remains at the forefront of MS research around the world. Through generous contributions from donors, corporate sponsors, and fervent fundraisers, the Multiple Sclerosis Society of Canada has invested over $190 million dollars in research since its inception in 1948. This investment has led to significant results for people affected by MS. More specifically, MS Society funded studies have gone the distance in areas such as imaging, diagnosis, genetics, tissue repair, rehabilitation, and disease-modifying therapies. With each passing year research continues to reveal new knowledge around the cause of MS, as well as the mechanism by which MS impacts the central nervous system.

Although much progress has been made, many questions regarding MS remain unanswered. As a result, Canadian researchers with diverse scientific backgrounds and expertise are turning their attention to MS and working together to uncover important knowledge and develop treatments that will effectively manage symptoms and slow progression. To ensure that momentum in MS research continues, the MS Society administers an annual research competition that provides support for researchers whether they are in the early stages of graduate school or conducting research as independent investigator. Funding researchers across the academic and clinical spectrum enables education and training for the next generation of MS leaders, while reinforcing their passion for the field.

In addition to supporting research, the MS Society engages young researchers in education and training programs, mentorship initiatives, and networking opportunities which aim to stimulate interest in MS research and encourage collaboration amongst the future generation of MS experts.

The overarching goal of the MS Society is to invest in research that will provide the greatest benefit to individuals who are deeply affected by MS. Each year the organization is hopeful that its commitment to research will bring the MS community one step closer to finding a cure for this complex and often unpredictable disease.